Key Statistics
Market Cap$31.95M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$5.73
52W High$8.08
52W Low$1.08
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
Employees—
Price Performance
1 Week-6.35%
3 Month-34.08%
1 Year-35.16%
FinancialsAnnual · QuiverQuant
Revenue$1.38M
Assets$73.70M
Liabilities$130.21M
Net Income$179.05M loss
About
BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze BTAI with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.